Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2001
03/07/2001EP1079805A1 Pharmaceutical composition comprising factor viii and neutral liposomes
03/07/2001EP1079804A1 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
03/07/2001EP1079803A2 Protein formulations
03/07/2001EP1079802A2 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities
03/07/2001EP1079801A1 A pharmaceutical formulation for nasal administration
03/07/2001EP0843591B1 Polyvinyl alcohol-based magnetic polymer particles, methods for their preparation and their use
03/07/2001EP0800384B1 Pharmaceutical tablet formulations for direct compression
03/07/2001EP0794770B1 Transdermal preparation containing a loratidine metabolite with antihistaminic activity
03/07/2001EP0729350B1 Hydrophobic preparations
03/07/2001CN1286725A Preservation of sensitive biological samples by vitrification
03/07/2001CN1286696A Liposomes comprising peptide antigens derived from X protein of hepatitis B virus
03/07/2001CN1286631A Tablets quickly disintegrating in oral cavity and process for producing same
03/07/2001CN1286630A Targeted liposome gene delivery
03/07/2001CN1286629A 片剂组合物 Tablet composition
03/07/2001CN1286625A Composition for aroma delivery
03/07/2001CN1286624A Composition for treatment of halitosis
03/07/2001CN1286594A Method of controlling release of antimicrobial agents in chewing gum and gum produced thereby
03/07/2001CN1286154A Laser borer for high-speed osmotic pump
03/07/2001CN1286118A Oral liquid of chitosan and lucid ganoderma and its preparing process
03/07/2001CN1286116A Medicine for treating cerebral infarction and its preparing process
03/07/2001CN1286105A Moxiburning medicine for acupoint therapy
03/07/2001CN1286093A Quickly-acting Chinese-medicinal ointment for treating burn and scald
03/07/2001CN1286083A Micropowdered tanshinone preparation and its microwave aided co-grinding process for preparing it
03/07/2001CN1286081A High-concentration super-fine perfluorocarbon emulsion for injection and its preparing process
03/07/2001CN1062854C Salmeterol kinafoate with controlled particulate size
03/07/2001CN1062770C Vaccine both for hepatitis A and measles, and production method therefor
03/07/2001CN1062766C Composition for health of smokers and preparing method therefor
03/07/2001CN1062758C Plaster for treating diseases caused by deficiency of kidney
03/07/2001CN1062755C Health-care tea for preventing cardiovascular and cerebrovascular diseases and its preparing method
03/07/2001CN1062749C Medicine for treating hyperlipemia and its preparing process
03/07/2001CN1062742C Method for preparing pantocrine injection
03/07/2001CN1062736C External use emulsion for treating burn
03/07/2001CN1062733C Liposome preparing process and preparation
03/07/2001CN1062732C Use of compositions based on alpha-pyrones for inducing and stimulating hair growth and/or retarding hair loss
03/07/2001CA2281837A1 Solid pharmaceutical composition comprising a retinoid and polyethylene glycol
03/06/2001US6198017 Adhesive which adheres to both dry and wet skin comprising mixture of hydrophilic acrylate copolymer containing tertiary amino groups, hydrophobic acrylate copolymer containing carboxyl groups, one or more acids, polyol, crosslinking agent
03/06/2001US6197935 Prion-free collagen and collagen-derived products and implants for multiple biomedical applications; methods of making thereof
03/06/2001US6197934 Compound delivery using rapidly dissolving collagen film
03/06/2001US6197836 Preparation of active ingredient dispersions and apparatus therefor
03/06/2001US6197829 For the transplantation of organs and autoimmune diseases. in order to inhibit rejection reaction at organs or bone marrow and treat autoimmune diseases and allergic diseases; fingolimod is title compound
03/06/2001US6197828 Derivatives of (+)-venlafaxine and methods of preparing and using the same
03/06/2001US6197823 Pain reliever and method of use
03/06/2001US6197813 At least one aldonic compound, a water-soluble zinc salt.
03/06/2001US6197801 Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction
03/06/2001US6197787 Pharmaceutical formulations containing poorly soluble drug substances
03/06/2001US6197781 Spray drying mixture of rapamycin suspension and carrier
03/06/2001US6197757 Particles, especially microparticles or nanoparticles, of crosslinked monosaccharides and oligosaccharides, processes for their preparation and cosmetic, pharmaceutical or food compositions in which they are present
03/06/2001US6197746 Method of using secretin for treating autism
03/06/2001US6197584 Antisense modulation of CD40 expression
03/06/2001US6197351 Treatment of endometrial mucosa of uterus tissues
03/06/2001US6197350 Method of producing a sustained-release preparation
03/06/2001US6197349 Supercooling a melt of poor water soluble substance, stabilizer, mixing and cooling
03/06/2001US6197348 Taste masked liquid suspensions
03/06/2001US6197347 Oral dosage for the controlled release of analgesic
03/06/2001US6197346 Administering to mucous membranes of patients
03/06/2001US6197345 Thrombolytic agents and methods of treatment for thrombosis
03/06/2001US6197344 Butorphanol sustained release formulations
03/06/2001US6197342 Impregnation of a biological active ceramic or glass
03/06/2001US6197341 Formulations of balsalazide and its derivatives
03/06/2001US6197340 Controlled release lipoic acid
03/06/2001US6197339 Dihydro-5-methylamino-4h-imidazo(4,5-ij)quinoline-2(1h)one butenedioate with starches and hydroxypropyl cellulose
03/06/2001US6197336 Ibuprofen with arginine and polyvinylpyrrolidone
03/06/2001US6197335 Dissolving cyclosporins with anionic surfactants
03/06/2001US6197334 Lozenge and method of making
03/06/2001US6197333 Materials and methods for making improved liposome compositions
03/06/2001US6197332 Lipid-conjugated polyamide compounds and related compositions and methods thereof
03/06/2001US6197331 Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
03/06/2001US6197329 Anti-nausea compositions and methods
03/06/2001US6197328 Nasally administrable compositions
03/06/2001US6197327 Device and method for treatment of dysmenorrhea
03/06/2001US6197326 Administering hyaluronic acid, chondroitin sulfate and salts by injection for joint pain
03/06/2001US6197324 Implanting local anesthetic into myocardial tissue
03/06/2001US6197323 Medicinal preparation containing a lipophilic inert gas
03/06/2001US6197317 Composition and method for the treatment of skin
03/06/2001US6197314 Impeding the extraction of active ingredients out of tablets
03/06/2001US6197311 Induction of cytotoxic T-lymphocyte responses
03/06/2001US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy
03/06/2001US6197290 Anion exchange resin-containing tablets
03/06/2001US6197288 Counteracting a malodor in the oral cavity of a mammal caused by a compound selected from the group consisting of lower carboxylic acids, thiiols, phenols, lower amines, phsophines and arsine by introdcing geranyl propionate in mouth cavity
03/06/2001US6197283 Using without emulsions as thickeners in cosmetic and pharmaceutical formulations
03/06/2001US6197280 Pharmaceutical compositions and devices for their administration
03/06/2001US6197279 Methods of delivering oxygen with emulsions
03/06/2001US6197229 Primary emulsion is formed which optionally contains a dna nicking inhibitor in addition to dna with or without buffer, temperature of the primary emulsion is lowered below the freezing point of the aqueous inner phase
03/06/2001US6196993 Ophthalmic insert and method for sustained release of medication to the eye
03/06/2001CA2132416C Use of transglutaminase inhibitor for the treatment of scar tissue
03/02/2001CA2316764A1 Food using y-aminobutyric acid-enriched cruciferous plant
03/01/2001WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
03/01/2001WO2001014415A2 Egfh2 genes and gene products
03/01/2001WO2001014411A1 Recombinant subunit vaccine
03/01/2001WO2001014393A2 Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms
03/01/2001WO2001014367A1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
03/01/2001WO2001014318A2 New effectors of dipeptidyl peptidase iv for topical use
03/01/2001WO2001014036A1 Process for producing fine medicinal substances
03/01/2001WO2001014011A1 Multi layer radiation delivery balloon
03/01/2001WO2001013986A1 Delivery system for therapy comprising hollow seeds, preferably metal, and use thereof
03/01/2001WO2001013968A1 Cyclodextrin containing pressure sensitive adhesives
03/01/2001WO2001013967A1 Solid wound healing formulations containing fibronectin
03/01/2001WO2001013956A2 Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
03/01/2001WO2001013955A1 Film forming polymers, methods of use, and devices and applications thereof
03/01/2001WO2001013954A1 Method of treating body insect infestation